Morgan Stanley’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-159,095
| Closed | -$14.8M | – | 8338 |
|
|
2021
Q4 | $14.8M | Buy |
159,095
+98,247
| +161% | +$6.47M | ﹤0.01% | 2499 |
|
|
2021
Q3 | $3.62M | Sell |
60,848
-32,121
| -35% | -$1.9M | ﹤0.01% | 4054 |
|
|
2021
Q2 | $6.34M | Buy |
92,969
+83,490
| +881% | +$5.44M | ﹤0.01% | 3524 |
|
|
2021
Q1 | $658K | Sell |
9,479
-52,620
| -85% | -$4.05M | ﹤0.01% | 4994 |
|
|
2020
Q4 | $4.77M | Buy |
62,099
+24,627
| +66% | +$1.85M | ﹤0.01% | 3307 |
|
|
2020
Q3 | $2.8M | Sell |
37,472
-8,308
| -18% | -$554K | ﹤0.01% | 3331 |
|
|
2020
Q2 | $2.88M | Buy |
45,780
+13,051
| +40% | +$718K | ﹤0.01% | 3234 |
|
|
2020
Q1 | $1.37M | Sell |
32,729
-52,927
| -62% | -$2.43M | ﹤0.01% | 3691 |
|
|
2019
Q4 | $3.89M | Sell |
85,656
-249
| -0.3% | -$11.8K | ﹤0.01% | 3465 |
|
|
2019
Q3 | $3.93M | Buy |
85,905
+44,392
| +107% | +$2.5M | ﹤0.01% | 3130 |
|
|
2019
Q2 | $2.43M | Sell |
41,513
-66,980
| -62% | -$3.46M | ﹤0.01% | 3629 |
|
|
2019
Q1 | $4.86M | Buy |
108,493
+2,879
| +3% | +$132K | ﹤0.01% | 2750 |
|
|
2018
Q4 | $4.11M | Sell |
105,614
-3,170
| -3% | -$124K | ﹤0.01% | 3114 |
|
|
2018
Q3 | $5.01M | Sell |
108,784
-25,267
| -19% | -$1.02M | ﹤0.01% | 3174 |
|
|
2018
Q2 | $5.84M | Buy |
134,051
+12,504
| +10% | +$537K | ﹤0.01% | 2971 |
|
|
2018
Q1 | $4.8M | Buy |
121,547
+6,644
| +6% | +$258K | ﹤0.01% | 3065 |
|
|
2017
Q4 | $3.9M | Buy |
114,903
+60,596
| +112% | +$1.73M | ﹤0.01% | 3367 |
|
|
2017
Q3 | $1.38M | Buy |
54,307
+2,047
| +4% | +$46.9K | ﹤0.01% | 4203 |
|
|
2017
Q2 | $881K | Sell |
52,260
-2,202
| -4% | -$30.2K | ﹤0.01% | 4464 |
|
|
2017
Q1 | $796K | Sell |
54,462
-19,893
| -27% | -$295K | ﹤0.01% | 4547 |
|
|
2016
Q4 | $1.06M | Buy |
74,355
+62,793
| +543% | +$973K | ﹤0.01% | 4423 |
|
|
2016
Q3 | $202K | Buy |
11,562
+7,013
| +154% | +$116K | ﹤0.01% | 5020 |
|
|
2016
Q2 | $77K | Sell |
4,549
-1,270
| -22% | -$22.7K | ﹤0.01% | 5364 |
|
|
2016
Q1 | $115K | Sell |
5,819
-4,309
| -43% | -$69.1K | ﹤0.01% | 5252 |
|
|
2015
Q4 | $193K | Sell |
10,128
-18,912
| -65% | -$386K | ﹤0.01% | 5100 |
|
|
2015
Q3 | $554K | Buy |
29,040
+15,001
| +107% | +$509K | ﹤0.01% | 4536 |
|
|
2015
Q2 | $652K | Sell |
14,039
-2,018
| -13% | -$87.5K | ﹤0.01% | 4518 |
|
|
2015
Q1 | $702K | Sell |
16,057
-1,677
| -9% | -$77.9K | ﹤0.01% | 4399 |
|
|
2014
Q4 | $615K | Sell |
17,734
-8,516
| -32% | -$346K | ﹤0.01% | 4521 |
|
|
2014
Q3 | $1.1M | Sell |
26,250
-218,642
| -89% | -$9.76M | ﹤0.01% | 3957 |
|
|
2014
Q2 | $14.3M | Buy |
244,892
+141,130
| +136% | +$8.89M | 0.01% | 1713 |
|
|
2014
Q1 | $6.54M | Buy |
103,762
+35,093
| +51% | +$2.33M | ﹤0.01% | 2332 |
|
|
2013
Q4 | $4.02M | Sell |
68,669
-75,417
| -52% | -$3.94M | ﹤0.01% | 2773 |
|
|
2013
Q3 | $7.59M | Buy |
144,086
+87,541
| +155% | +$5.88M | ﹤0.01% | 2030 |
|
|
2013
Q2 | $4.35M | Buy |
+56,545
| New | +$4.62M | ﹤0.01% | 2460 |
|
Morgan Stanley's ARNA Position: Q1 2022 in Review
Morgan Stanley sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 159,095 shares — an estimated $14.8M sold.
Morgan Stanley first reported a position in ARNA in Q2 2013 and held it in 35 quarters. The position peaked at $14.8M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Morgan Stanley reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Morgan Stanley sold 159,095 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $14.8M.
- Morgan Stanley first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 35 quarters.
- Morgan Stanley's Arena Pharmaceuticals Inc position peaked at $14.8M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Morgan Stanley's 13F filing for Q1 2022, filed 13 May 2022.